Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Der Nervenarzt|September 1, 1995
[Chronification of sleep disorders. Results of a representative survey in West Germany]S Simen, G Hajak, G Schlaf, et al.
Pharmacopsychiatry|September 1, 1996
Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomniaG Hajak, A Rodenbeck, L Adler, et al.
Neuropsychobiology|January 1, 1997
Exercise avoidance and impaired endurance capacity in patients with panic disorderA Broocks, T F Meyer, B Bandelow, et al.
Der Nervenarzt|May 5, 1998
[The social status of schizophrenic patients]P Müller, W Gaebel, B Bandelow, et al.
Laboratory Animals|October 14, 2004
WKY/Ztm-ter: a new rat inbred strain on the WKY/Ztm genetic background with congenital teratomasB Länger, M Dorsch, K Gärtner, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 27, 2018
Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI studyA Uhlmann, B Bandelow, D J Stein, et al.
The American Journal of Psychiatry|May 20, 1998
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorderA Broocks, B Bandelow, G Pekrun, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1992
Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of GermanyB Bandelow, P Müller, U Frick, et al.
Diabetologia|April 15, 2011
The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus)E Peschke, K Hofmann, I Bähr, et al.
Deutsche Medizinische Wochenschrift (1946)|December 8, 2000
[Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome]S Heindl, C Binder, H Desel, et al.
Pageof 10